Fred Alger Management Inc. trimmed its holdings in shares of Agilent Technologies Inc (NYSE:A) by 1.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 85,280 shares of the medical research company’s stock after selling 996 shares during the quarter. Fred Alger Management Inc.’s holdings in Agilent Technologies were worth $5,711,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Dupont Capital Management Corp purchased a new stake in shares of Agilent Technologies during the third quarter worth approximately $101,000. Front Row Advisors LLC purchased a new stake in shares of Agilent Technologies during the fourth quarter worth approximately $106,000. AMG National Trust Bank purchased a new stake in shares of Agilent Technologies during the fourth quarter worth approximately $201,000. Steward Partners Investment Advisory LLC purchased a new stake in shares of Agilent Technologies during the third quarter worth approximately $213,000. Finally, Cannell Peter B & Co. Inc. purchased a new stake in shares of Agilent Technologies during the third quarter worth approximately $215,000.
A has been the subject of several research reports. Morgan Stanley reiterated an “overweight” rating on shares of Agilent Technologies in a research report on Tuesday, November 14th. Zacks Investment Research cut Agilent Technologies from a “buy” rating to a “hold” rating in a report on Thursday, November 16th. Deutsche Bank set a $75.00 target price on Agilent Technologies and gave the company a “buy” rating in a report on Tuesday, November 21st. JPMorgan Chase & Co. upped their target price on Agilent Technologies to $75.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. Finally, Barclays upped their target price on Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. Five equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $70.98.
Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 14th. The medical research company reported $0.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.58 by $0.08. The company had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.16 billion. Agilent Technologies had a return on equity of 17.70% and a net margin of 4.25%. During the same period in the prior year, the business earned $0.53 EPS. equities research analysts anticipate that Agilent Technologies Inc will post 2.67 earnings per share for the current year.
In other news, CEO Michael R. Mcmullen sold 43,703 shares of the stock in a transaction on Friday, January 5th. The stock was sold at an average price of $70.00, for a total transaction of $3,059,210.00. Following the completion of the transaction, the chief executive officer now directly owns 302,837 shares in the company, valued at approximately $21,198,590. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Michael R. Mcmullen sold 21,850 shares of the stock in a transaction on Monday, January 29th. The stock was sold at an average price of $75.00, for a total value of $1,638,750.00. Following the transaction, the chief executive officer now owns 324,687 shares of the company’s stock, valued at $24,351,525. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 102,970 shares of company stock valued at $7,340,641.
ILLEGAL ACTIVITY NOTICE: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/03/12/agilent-technologies-inc-a-shares-sold-by-fred-alger-management-inc.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.